Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07219888 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Comparison of Suzetrigine and Oxycodone for Postoperative Pain After Primary Total Knee Arthroplasty

StatusEnrolling by Invitation
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Not Yet Recruiting to Enrolling by Invitationv3 Show 4 more changesShow less
    • Primary completion date: Apr 30, 2026 to Dec 31, 2026
    • Study sites: 0 to 1
    • Study completion date: May 29, 2026 to Apr 30, 2027
    • Start date changed from estimate of Dec 1, 2025 to Feb 9, 2026
  2. Primary endpoints: 6 to 5v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose this study is determine whether postoperative oral dosage of suzetrigine is effective at controlling postoperative pain and reducing analgesic requirements following primary total knee arthroplasty (TKA) versus a control group of TKA patients receiving postoperative Oxycodone.
Trial Details
NCT Number NCT07219888
Lead Sponsor University of Louisville
Conditions
(from sponsor)		 Osteoarthritis (OA) of the Knee
Related terms Osteoarthritis
Enrollment 140 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov